An antioxidant nanozyme for targeted cardiac fibrosis therapy post myocardial infarction

An antioxidant nanozyme for targeted cardiac fibrosis therapy post myocardial infarction

Abstract The excessive release of reactive oxygen species (ROS) after myocardial infarction (MI) disrupts the natural healing process, leading to cardiac fibrosis and compromising patient prognosis. However, the clinical application of many antioxidant drugs for MI treatment is hindered by their poo...

Full description

Saved in:
Bibliographic Details
Main Authors: Ziyi Gu, Xueliang Liu, Zhen Qi, Zhou Fang, Yiting Jiang, Yuting Huang, Yongyi Wang, Lianming Wu, Yu Yang
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Journal of Nanobiotechnology
Subjects:
Cardiac fibrosis
Myoardial infarction
Nanozyme
Heart-targeted
Online Access:https://doi.org/10.1186/s12951-024-03047-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12951-024-03047-6

Similar Items